Red cell glycolytic enzyme disorders caused by mutations: An update

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 9, Issue 2, 2009, Pages 95-106

  Climent, Fernando ^a   Roset, Feliu ^a   Repiso, Ada ^a   de la Ossa, Pablo Pérez ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Glycolytic enzymes; Mutation; Red cells; Structure

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; ASPARTIC ACID; BISPHOSPHOGLYCERATE MUTASE; CYSTEINE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; GLYCOLYTIC ENZYME; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE MUTASE; PYRUVATE KINASE; THREONINE; TRIOSEPHOSPHATE ISOMERASE; TRYPTOPHAN; TYROSINE; VALINE;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CARDIOMYOPATHY; CRYSTAL STRUCTURE; DISEASE SEVERITY; ENZYME DEFECT; ENZYME STRUCTURE; ERYTHROCYTE DISORDER; ERYTHROCYTOSIS; GENE MUTATION; GENE SEQUENCE; GLYCOGEN STORAGE DISEASE; GLYCOLYSIS; HEMOLYTIC ANEMIA; HUMAN; INFECTION; MENTAL DEFICIENCY; METASTASIS; MYOGLOBINURIA; MYOPATHY; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPHEROCYTOSIS; STOP CODON; TRANSLATION REGULATION; ZELLWEGER SYNDROME;

ANEMIA, HEMOLYTIC; ANIMALS; BISPHOSPHOGLYCERATE MUTASE; ERYTHROCYTES; GLUCOSE-6-PHOSPHATE ISOMERASE; GLYCOLYSIS; HUMANS; ISOMERASES; MUTATION; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE MUTASE; PYRUVATE KINASE; TRANSFERASES; TRIOSE-PHOSPHATE ISOMERASE;

EID: 68349120552     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152909788488636     Document Type: Article

References (147)

1. Walker, J.I.H.; Morgan, M.J.; Faik, P. Structure and organization of the human glucose phosphate isomerase gene (GPI). Genomics, 1995, 29, 261-265.
2. Achari, A.; Marshall, S.E.; Muirhead, H.; Palmier, A.; Noltman, E.A. Glucose 6-phosphate isomerase. Philos. Trans. R. Soc. London. Biol., 1981, 293, 145.
3. Sun, Y.J.; Chou, C.C.; Chen, W.S.; Wu, R.T.; Men, M.; Hsiao, C.D. The crystal structure of a multifunctional protein: phosphoglucose isomerase/ autocrine motility factor/neuroleukine. Proc. Nat. Acad. Sci. USA, 1999, 243, 1401-1414.
4. Jeffery, C.J.; Bahnson, B.J.; Chien, W.; Ringe, Petsko, A. Crystal structure of rabbit phosphoglucose isomerase, a glycolytic enzyme that moonlights as neuroleukine, autocrine motility factor and differentiation mediator. Biochemistry, 2000, 39, 955-964.
5. Read, J.; Pearce, J.; Li, H.; Muirhead, H.; Chirwing, J.; Davies, C. The crystal structure of human phosphoglucose isoemerase at 1.6 A resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia. J. Mol. Biol. 2001, 309, 447-463.
6. Kugler. W.; Lakomek, M. Glucose-phosphate isomerase deficiency. Baillière's Clin. Hematol., 2000, 13. 89-101.
7. Cordeiro, A.T.; Godoi, P.H.C.; Silva, C.H.T.P.; Garratt, R.C.; Oliva, G.; Thiemann, O.H. Crystal structure of human phosphoglucose isomerase and analysis of the initial catalytic steps. Biochem. Biophys. Acta, 2003, 1645, 117-122.
8. Gurney, M. E.; Heinrich, S.P.; Lee, M. R.; Yin, H. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science. 1986, 234, 566-574.
9. Van Bieruliet, J.P.; Van Milligen-Boersma, L.; Staal, G.E. A new variant of glucosephosphate isomerase deficiency (GPI- Utrecht). Clin. Chim. Acta, 1975, 65, 157-165.
10. Zanella, A.; Izzo C.; Rebulla, P.; Perrni, L.; Mariani, M.; Canestri, G.; Sansome, G.; Sirchia, G. The first stale variant of erythrocyte glucose-phosphate isomerase associated with severe hemolytic anemia. Am. J. Hematol., 1980, 9, 1-14.
11. Schroter, W.; Eber, S.W.; Bardosi, A.; Gahr, M.; Gabriel, M.; Sitzman, F.C. Generalised glucosephosphate isomerase (GPI) deficiency causing haemolytic anaemia, neuromuscular symptoms and impairment of granulocytic function: a new syndrome due to a new stable GPI variant with diminished specific activity (GPI Homburg). Eur. J. Pediatr., 1985, 144, 301-305.
12. Decourt, B.; Bouleau, Y.; Dulon, D.; Hafidi, A. Expression analysis of neuroleukin, calmodulin, cortactin and Rho7/Rnd2 in the intact and injured mouse brain. Brain Res. Des. Brain Res., 2005, 159, 36-54.
13. Repiso, A.; Andrés, R.; Climent, F.; Ureña, J.M. Expression patterns in mouse embryos of neuroleukin/glucose-6-phosphate isomerase and autocrine motility factor receptor. Anat. Histol. Embryol., 2008, 37, 380-382.
14. Nabi, I.; Watanabe, H.; Raz, A. Autocrine motility factor and its receptor: role in cell locomotion and metastasis. Cancer Metastasis Rev., 1992, 11, 5-20
15. Watanabe, H.; Takehana, K.; Date, M.; Shinozaki, T.; Raz A. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase peptide. Cancer Res., 1996, 56, 2960-2963.
16. Tsutsumi, S.; Hogan, V.; Nabi, I.R.; Raz A. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res., 2003, 63, 242-249.
17. Funasaka, T.; Hu, H.; Hogan, V.; Raz, A. Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosome cells to oxidative stress leading to cellular senescense. J. Biol. Chem., 2007, 282, 36362-36369.
18. Xu, W.; Seiter, K.; Feldman, E.; Ahmed, T.; Chiao J.W. The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood, 1996, 87, 4502-4506.
19. Repiso, A.; Oliva, B.; Vives corrons, J.L.; Carreras, J.; Climent, F. Glucose phosphate isomerase deficiency: enzymatic and familial characterization of Arg346His mutation. Biochim. Biophys. Acta, 2005, 1740, 467-471.
20. Repiso, A.; Oliva, B.; Vives Corrons, J.L.; Beutler, E.; Carreras, J.; Climent, F. Red cell glucose phosphate isomerase (GPI): a molecular study of three novel mutations associated with hereditary nonspherocytic hemolytic anemia. Hum. Mutat., 2006, 937, 27, 1159.
21. Clarke, J.L.; Vulliamy, T.J.; Roper, D.; Mesbah-Namin, S.A.; Wild, B.J.; Walker, J.I.; Will, A.M.; Bolton-Maggs, P.H.; Mason, P.J.; Layton, D.M. Combined glucose-6-phosphate dehydrogenase and glucose phosphate isomerase deficiency can alter clinical outcome. Blood Cell Mol. Dis., 2003, 87, 258-253.
22. Walker, J.I.H.; Layton, D.M.; Bellingham, A.J.; Morgan, M.J.; Faik, P. DNA sequence abnormalities in human glucose-6-phosphate isomerase deficiency. Hum. Mol. Genet., 1993, 2, 327-329.
23. Vives-Corrons, J.L.; Rozman, C.; Kahn.; Carrera, A.; Triginer J. Glucose phosphate isomerase deficiency with hereditary hemolytic anemia in a Spanish family: clinical and familial studies. Hum. Genet., 1975, 29, 291-297.
24. Kahn, A.; Vives J.L.; Bertrand, O.; Cottreau, D.; Marie, J.; Boivin, P. Glucose-phosphate isomerase deficiency due to a new variant (GPI-Barcelona) and to a silent gene: biochemical, immunological and genetic studies. Clin. Chim. Acta, 1976, 66, 145-155.
25. Schroter, W.; Brittinger, G.; Zimmerschmitt, E.; Konig, E.; Schareder, D. Combined glucose phosphate isomerase and glucose-6-phosphate dehydrogenase deficiency of the erythrocytes: a new haemolytic syndrome. Br. J. Haemat., 1971, 20, 249-261
26. Sanpitak, N.; Supalert, Y.; Chayutimonkul, L.; Flatz, G. Combined erythrocyte phosphohexose isomerase and glucose-6-phosphate dehydrogenase deficiency. Hum. Hered, 1973, 23, 83-87.
27. Steidman, I.; Kaufman, S.; Zaidman, J.L.; Laiba, H. Combined glucose phosphate isomerase and glucose-6-posphate dehydrogenase deficiency of erythrocytes. Isr. J. Med. Sci., 1978, 14, 1186-1190.
28. Arnold, H.; Lohr, G.W.; Hasslinger, K.; Ludwig, R. Combined erythrocyte glucose phosphate isomerase (GPI) and glucose-6-posphate dehydrogenase (G6PDH) deficiency in an Italian family. Hum. Genet., 1981, 57, 226-229.
29. Brown, J.R.; Daar, I.O.; Krug, J.R.; Maquat, L.E. Characterization of the functional gene and several processed pseudogenes in the human triosephosphate isomerase gene family. Mol. Cell Biol., 1985, 5, 1694-1706.
30. Mande, S.C.; Mainfrod, V.; Kalk, K.H.; Goraj, K.; Martial, J.A.; Hol, W.G.H. Crystal structure of recombinant human triosephosphate isomerase at 2.8A resolution. Triosephosphate isomerase-related human genetics disorders and comparison with the trypanosomal enzyme. Prot. Sci., 1994, 3, 810-821.
31. Cansu, S.; Doruker, P. Dimerization affects collective dynamics of triodephosphate ismerase. Biochemistry, 2008, 47, 1388-1368.
32. Sneider, A.S.; Valentine, W. N.; Hattori, M.D.; Heins, L.H. Hereditary hemolytic anemia with triosephosphate isomerase deficiency. N. Engl. J. Med., 1965, 272, 229-235.
33. Orosz, F.; Oláh, J.; Ovádi, J. Triosephosphate isomerase deficiency: Facts and Doubts. IUBMB Life, 2006, 58, 703-715.
34. Orosz, F.; Wágner, G.; Liliom, K.; Kovács, J.; Baróti, K.; Horány M.; Farkas, T.; Hollán.S.; Ovádi, J. Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules. Proc. Natl. Acad. Sci. USA, 2000, 97, 1026-1031.
35. Oláh, J.; Orosz, F.; Keserü, G.M.; Kovári, A.; Kovács, J. Hollán, S.; Ovádi J. Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease. Biochem. Soc. Trans., 2002, 30, 30-38.
36. Oláh, J.; Orosz, F.; Puskás, L.G.; Hackler, L.; Horány, M.; Polgár, L.; Hollán, S.; Ovádi, J. Triosephosphate isomerase deficiency: consequences of an inherited mutation at mRNA, protein and metabolic levels. Biochem. J., 2005, 392, 675-683.
37. Schneider, A.S. Triosephosphate isomerase deficiency: historical perspectives and molecular aspects. Baillière's Clin. Haematol., 2000, 13, 119-140.
38. Schneider, A.S.; Dunn, I.; Weinstein, I.M. In Triosephosphate isomerase deficiency.; Beutler, E., Ed.; City of Hope Symposium Series: New York, London, 1968; Vol. 1, pp. 273-279.
39. Skala, H.; Dreyfus, J.L.; Vives Corrons, J.L.; Matsumoto, F.; Beurler, E. Triose phosphate isomerase deficiency. Biochem. Med., 1977, 18, 226-234.
40. Decker, R.S.; Mohrenweiser, H.W. Origin of the triosephosphate isomerase isozymes in humans: genetic evidence for the expression of a single structural locus. Am. J. Hum. Gen., 1981, 33, 683-691.
41. Jongsma, A.P.M.; Los, W.R.T.; Hagemeijer, A. Evidence for synteny between the human loci for triose phosphate isomerase, lactate dehydrogenase-B and peptidase-B and the regional mapping on chromosome 12 of man. Cytogen. Cell Genet., 1974, 13, 106-107.
42. Jongsma, A.P.M.; Hagemeijer, A.; Khan, P.M. Regional mapping of TPI, LDH-B and Pep-B on chromosome 12 of man. Birth Defects 1975, 11, 189-191.
43. Maquat, L.E.; Chilcote, R.; Ryan, P.H. Human triosephosphate isomerase cDNA and protein structure: studies of triosephosphate isomerase in man. J. Biol. Chem., 1985, 260, 3748-3753.
44. Boyer, T.G.; Maquat, L.E. Minimal sequence and factor requirements for the initiation of transcription from an atypical TATA-TAA box-containing housekeeping promoter. J. Biol. Chem., 1990, 265, 20524-20532.
45. Wierenga, R.K.; Noble, M.E.M.; Davenport, R.C. Comparison of the refined crystal structures of liganded and unliganded chicken, yeast and trypanosomal triosephosphate isomerase. J. Mol. Biol., 1992, 224, 1115-1126.
46. Ralser, M.; Breitenbach, M,.; Lehrach, H.; Kroitschs, S. Triosephosphate isomerase deficiency is caused by altered dimerization-non catalytic activity of the mutant enzyme. PloS One, 2006, 1, e30.
47. Repiso, A.; Boren, J., Ortega, F.; Pujades, A.; Centelles, J.; Vives-Corrons, J.L.; Climent, F.; Cascante, M.; Carreras, J. Triosephosphate isomerase deficiency. Genetic, enzymatic and characterization of a new case from Spain. Haematologica, 2002, 87(04), ECR12.
48. Watanabe, M.; Zing, B.C.; Mohrenweiser, H.W. Molecular analysis of a series of alleles in humans with reduced activity at the triosephosphate isomerase locus. Am. J. Hum. Genet., 1996, 58, 308-316.
49. Sneider, A.; Cohen-Solal, M. Hematologically important mutations: triosephosphate isomerase. Blood Cells Mol. Dis., 1996, 22, 82-84.
50. Schneider, A.; Forman, L.; Westwood, B.; Yim, C.; Lin, J.; Singh, S.; Beuler, E. The relationship of the -5, -8 and -24 variant alleles in African Americans to triosephosphate isomerase (TPI) enzyme activity and to TPI deficiency. Blood, 1998, 92, 2959-2962.
51. Valentine, C.; Pissard, S.; Artin, J.; Heron, D.; Labrune, P.; Livet, M.O.; Mayer, M.; Gelbart, T.; Schneider, A.; Mav-Audit, P.; Cohen-Solal, M. Triosephosphate isoemerase deficiency in 3 French families: two novel null alleles, a frameshift mutation (TPI Alfortville) and an alteration in the initiation codon (TPI Paris). Blood, 2000, 96, 1130-1135.
52. Daar, I.O.; Artymiuk, P.J.; Phillips, D.C.; Maquat, L.E. Human triose-phosphate isomerase deficiency: a single aminoacid substitution results in a thermolabile enzyme. Proc. Natl. Acad. Sci. USA, 1986, 83, 7903-7907.
53. Ationu, A.; Humphries, A.; Alloz, M.R.A.; Arya, R.; Wild, B.; Warrilow, J.; Morgan, J.; Bellingham, J.; Layton, D.M. Reversal of metabolic block in glycolysis by enzyme replacement in triosephosphate isomerase-deficient cells. Blood, 1999, 94, 3193-3198.
54. Celotto, A.M.; Frank, A.C.; Seigle, J.L.; Palladino, M.J. Drosophila model of human inherited triosephosphate isomerase deficiency glycolytic enzymopathy. Genetics, 2006, 174, 1237-1246.
55. Eagle, J.L.; Celotto, A.M.; Palladino, M. Degradation of functional TPI protein underlies sugar kill pathology. Genetics, 2008, 179, 855-862.
56. Shaw-Lee, R.L.; Lissemora, J.L.; Sullivan, D.T. Structure and expression of the triosephosphate isomerase (Tpi) gene of Drosophila melanogaster. Mol. Gen. Genet., 1991, 230, 225-229.
57. Repiso, A.; Vives-Corrons, J.L.; Vulliamy, T.; Killeen, N.; Layton,.; Carreras, J.; Climent, F. New haplotype for the Glu104Asp mutation in triose-phosphate isomerase deficiency and prenatal diagnosis in a Spanish family. J. Inherit. Metab. Dis., 2005, 28, 807-809.
58. Bardosi, A.; Eber, S.W.; Hendrys, M.; Pekrun, A. Myopathy with altered mitochondria due to a triosephosphate isomerase deficiency. Acta Neuropathologica,, 1990, 79, 387-384.
59. Eber, S.W.; Pekrun, A.; Bardosi, A.; Gahr, M.; Kristach, W.K.; Krüger, J.; Matthei, R.; Schröter, W. Triose phosphate isomerase deficiency: haemolytic anaemia myopathy with altered mitochondria and mental retardation due to a new variant with accelerated enzyme catabolism and diminished specific activity. Eur. J. Pediatr., 1991, 150, 761-766.
60. Asakawa, J.; Mohrenwisser, H. W. Characterization of two new electrophoretic variants of human triose phosphate isomerase: stability, kinetic and immunological properties. Biochem. Genet., 1982, 20, 5976.
61. Perry, B.A.; Mohrenweisser, H.W. Humantriosephosphate isomerase: substitution of Arg for Gly at position 122 in a thermolabile electrophorm variant. Hum. Genet., 1992, 88, 634-638.
62. Arya, R.; Lalloz, M.R.; Bellingham, A.J.; Layton, D.M. Evidence for founder effect of the Glu104Asp substitution and identification of a new mutation in triosephosphate isomerase. Hum. Mut., 1997, 10, 290-294.
63. Wilmshurst, J.M.; Wise, G.A.; Pollard, J.M.; Ouvrier, R.A. Chronic axonal neuropathy with triosephosphate isomerase deficiency. Ped. Neurol., 2004, 30, 146-148.
64. Sneider, A.; Westwood, B.; Yim, C.; Cohen-Solal, M.; Rosa, R.; Labotka, R.; Eber, S., Wolf, R.; Lammi, A.; Beutler, E. The 1591C mutation in triosephosphate isomerase (TPI) deficiency. Tightly linked polymorphisms and a common haplotype in all known families. Blood Cells Mol. Dis., 1996, 22, 115-125.
65. Daar, I.O.; Maquat, L.E. Premature translation mediates triosephosphate isomerase mRNA degradation. Mol. Cell Biol., 1988, 8, 802-813.
66. Hollán, S.; Fujii, H.; Hirono, A.; Hirono, K.; Karro, H.; Miwa, S.; Harsányi, V.; Inselt-Kovács, M. Hereditary triosephosphate isomerase (TPI) deficiency: two severely affected brothers one with and one without neurological symptoms. Hum. Genet., 1993, 92, 486-490.
67. Chang, M.L.; Artymiuk, P.J.; Wu, X.; Hollán, S.; Lammi, A.; Maquat, L.E. Human triosephosphate isomerase deficiency resulting from mutations of Phe-240. Am. J. Human Genet., 1993, 52, 1260-1269.
68. Humphries, A.; Ationu, A.; Wild, Layton, D.M. The consequence of nucleotide substitutions in the triosephosphate isoemerase (TPI) gene promoter. Blood Cells Mol. Dis., 1999, 25, 210-217.
69. Jindal, H.K.; Vishwanatha, J.K.; Functional identity of a primer recognition protein as phosphoglycerate kinase. J. Biol. Chem., 1990, 265, 6540-6543.
70. Shichijo, S.; Azuma, K.; Komatsu, N.; Ito, M.; Maeda, Y.; Ishihara, Y.; Itoh, K. Two proliferation-related proteins, TYMS and PGA1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer. Clin. Cancer Res., 2004, 10, 5828-5436.
71. Mc Carrey, J.R.; Thomas, K. Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene. Nature, 1987, 326, 501-505.
72. Chen, S.H.; Donahue, R.P.; Scott, C.R. Characterization of phosphoglycerate kinase, an X-linked polymorphism in man. Fertil. Steril., 1976, 27, 699-701.
73. Michelson, A.M.; Bruns, G.A.; Morton, C.C.; Orkin, S.H. The human phosphoglyerate kinase multigene family. HLA-associated sequences and an X-linked locus containing a processed pseudogene and its functional counterpart. J. Biol. Chem., 1985, 260, 6982-6992.
74. Beutler, E. PGK deficiency. Br. J. Haematol., 2007, 136, 3-11.
75. Flachner, B.; Vargas, A.; Gugolya, Z.; Vonderviszt, F.; Vas, M. Role of phosphate chain mobility of MgATP in completing the 3-phosphoglycerate kinase catalytic site: binding, kinetic and crystallographic studies with ATP and MgATP. Biochemistry, 2004, 43, 34-36
76. Noel, N.; Flanagan, J.M.; Bajo, M.J.R.; Kalko, S.G.; Mañú, M.; Fuster, J.L.; Perez de la Ossa, P.; Carreras, J.; Beutler, J. Vives Corrons, J.L. Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. Br. J. Haematol., 2005, 132, 523-529.
77. Aasly, J.; van Diggelen, P.P.; Boer, A.M.; Brønstad, G. Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symstoms. Eur. J. Neurol., 2000, 7, 111-113.
78. Svaansand, E.V.; Aasly, J.; MalmLandsem, V.; Klungland, H. Altered expression of PGK1 in a family with phosphoglycerate kinase deficiency. Muscle Nerve, 2007, 36, 679-684.
79. Fothergill-Gilmore, L.A.; Watson, H.C. The phosphoglycerate mutases. Adv. Enzymol., 1989, 62, 227-313.
80. Carreras J.; Bartrons, R.; Climent, F.; Cussó, R. Bisphosphorylated metabolism and molecular biology. Adv. Clin. Enzymol., 1986, 4, 118-134.
81. Carreras J.; Bartrons, R.; Climent, F.; Cussó, R. Bisphosphorylated metabolites of glycerate, glucose and fructose: functions, metabolism and molecular pathology. Clin. Biochem., 1986, 19, 348-358.
82. Joulin, V.; Garel, M.C.; Le Boulch, P.; Valentin, C.; Rosa, R.; Rosa, J., Cohen-Solal, M. Isolation and characterization of the human 2, 3-bisphosphoglycerate gene. J. Biol. Chem., 1998, 263, 15785-15790.
83. Haggarty, N.; Dunbar, B.; Fothergill, L.A. The complete aminoacid sequence of human erythrocyte diphosphoglycerate mutase. EMBO J., 1983, 2, 1213-1220.
84. Joulin, B.; Peduzzi, J.; Roméo, D.H.; Rosa, J.; Valentin C.; Dubart, A.; Lapeyre, B.; Blouquit, Y.; Garel, M.C.; Goossens, M.; Rosa, J.; Cohen-Solal, M. Molecular cloning and sequencing of the human erythrocyte 2, 3-bisphosphoglycerate mutase cDNA: revises aminoacid sequence. EMBO J., 1986, 5, 2275-2283.
85. Cherfils, J.; Rosa, R.; Garel.; Calvin.; Rosa J, Janin J. Crystallization and preliminary X-ray diffraction studies of the human erythrocyte bisphosphoglycerate mutase. J. Mol. Biol., 1991, 218, 269-270.
86. Wang, Y.; Wei, Z.; Biab, Q.; Cheng, Z., Wan, M.; Liu, L.; Gong, W. Crystal structure of human bisphosphoglycerate mutase. J. Biol. Chem., 2004, 279, 39132-39138.
87. Rosa, R.; Prehu, M.O.; Benzard, Y.; Rosa, J. The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes. J. Clin. Invest., 1978, 62, 907-915.
88. Labie, D.; Leroux, J.P.; Najman, A.; Reyrolle, C. Familial diphosphoglycerate mutase deficiency. Influence of the oxygen affinity curves of hemoglobin. FEBS Lett. 1970, 9, 37-40.
89. Travis, S.F.; Martinez, J. Garvin, J. Study of a kindred with red cell 2, 3-diphosphoglycerate mutase deficiency and compensated hemolysis. Blood, 1976, 48, 104 (Abstract).
90. Rosa, R.; Blouquit, Y.; Calvin, M.C.; Prome, D.; Prome, J.C. Isolation, characterization and structure of a mutant 89Arg→Cys bisphosphoglycerate mutase. J. Biol. Chem., 1989, 264, 7837-7843.
91. Lemarchel, V.; Joulin, V.; Valentin.; Rosa, R.; Galactéros, F., Rosa, J.; Cohen-Solal, M. Compound heterozygosity in a complete erythrocyte bisphosphoglycerate mutase deficiency. Blood, 1992, 80, 2643-2649.
92. Hoyer, J.D.; Allen, S.L.; Beutler, E.; Kubik, K.; West, C.; Fairbanks, V.F. Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Am. J. Hematol., 2004, 75, 2005-2008.
93. Graña, X.; Ureña. J.; Ludevid. D.; Carreras. J.; Climent, F. Purification, characterization and immunological properties of 2, 3-bisphosphoglycerate-independent phosphoglycerate mutase of maize ( Zea mays) seeds. Eur. J. Biochem., 1989, 186, 149-153.
94. Graña, X.; de Lecea, L.; El-Maghrabi, L.; Ureña, J.; Caellas, C.; Carreras, J.; Puigdomenech, P.; Pilkis, S.J.; Climent, F. Cloning and sequence of a cDNA encoding 2, 3-bisphosphoglycerate-independent phosphoglycerate mutase from maize. J. Biol. Chem., 1992, 267, 12797-12803.
95. Graña, X.; Broceño, C.; Garriga, J.; Pérez de la Ossa, P.; Climent, F. Phosphoglycerate mutase activity and mRNA levels during germination of maiza embryos. Plant Sci., 1993, 89, 147-151.
96. Graña, X.; Pérez de la Ossa, P.; Broceño, C.; Stöcker, M.; Garriga, J.; Puigdomenech, P.; Climent, F. 2, 3-bisphosphoglycerate - independent phosphoglycerate mutase is conserved among different phylogenetic kingdoms. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 1995, 112B, 287-293.
97. Nairn, J.; Price, N.C.; Fothergill-Gilmore, L.A.; Walker, G.E.; Fothrgill, J.E.; Dunbar, B. The amino sequence of the small monomeric phosphoglycerate mutase from the fission yeast Schizosaccharomyces pombe. Biochem. J., 1994, 297, 603-608.
98. Leyva-Vazques, M.A.; Setlow, P. Cloning and nucleotide sequences of the gene encoding triosephosphate isomerase, phosphoglycerate mutase and enolase from Bacillus subtilis. J. Bacteriol., 1994, 176, 3309-3910.
99. Pérez de la Ossa, P.; Graña, X.; Ruiz-Lozano, P.; Climent, F. Isolation and characterization of cofactor-independent phosphoglycerate mutase gene from maize. Biochem. Biophys. Res. Commun., 1994, 203, 1204-1209.
100. Jedrzejas, M.; Chander, M.; Setlow, P.; Krihnasamy, G. Structure and mechanism of action of a novel phosphoglycerate mutase from Bacillus stearothermophilus. EMBO J. 2000, 19, 1419-1431.
101. Johnsen, U.; Schöuheit, P. Characterization of cofactor-dependent and cofactor- independent phosphoglycerate mutases from Archaea. Extremophiles, 2007, 11, 647-657.
102. Omenn, G.G.; Hermodson, M.A. Human phosphoglycerate mutase: isozyme marker for muscle differentiation and for neoplasia. In Developmental Biology, Market, C.L., Ed.; Academic Press.; New York, 1994; Vol. III, pp. 1005-10018.
103. Tsujino, S.; Sakoda, S.; Mizuno, R.; Kobayashi, T.; Susuki, T.; Kishimoto, S.; Shanske, S.; DiMauro, S.; Schon, E.A. Structure of the gene encoding the muscle-specific subunit of human phosphoglycerate mutase. J. Biol. Chem., 1989, 264, 15334-15337.
104. Castella-Escola, J.; Ojcius, D.M.; LeBoulch, P.; Joulin, V.; Blouquit, Y.; Garel, M.C.; Valentin, C.; Rosa, R.; Climent-Romeo, F.; Cohen-Solal, M. Isolation and characterization of the gene encoding the muscle-specific isozyme of human phosphoglycerate mutase. Gene, 1990, 91, 225-232.
105. Junien, C.; Despoisse, S.; Turlean, C.; de Grouchy, J.; Bucher, T.; Fundele, R. Assignment of phosphoglycerate mutase (PGAMA) to human chromosome 10. Regional mapping of GOT1 and PGAMA to subbands 10q26.1 (or q23.3). Ann. Genet., 1982, 25, 25-27.
106. Zhang, J.; Yu. L.; Quiang, F.; Gao, J.; Xie, Y.; Chen, J.; Zhang, P.; Liu. Q.; Zhao, S. Mouse phosphoglycerate mutase M and B isozyme: cDNA cloning, enzyme activity assay and mapping. Gene, 2001, 264, 273-279.
107. Wang. Y.; Wei. Z.; Liu, L.; Cheng. Z.; Lin, Y.; Fengyuan, J.; Gong. Crystal structure of human B-type phosphoglycerate mutase bound with citrate. Biochem. Biopys, Res. Commun., 2005, 331, 1207-1215.
108. Carreras, J.; Bartons, R.; Grisolia, S. Vanadate inhibits 2, 3-bisphosphoglycerate dependent phosphoglycerate mutases but not affect the 2, 3-bisphosphoglycerate independent phosphoglycerate mutases. Biochem. Biophys. Acta, 1980, 96, 1267-1273.
109. Vives-Corrons, J.L.; Jou, J.N.; Ester, A.; Ibars, M.; Carreras, J.; Bartrons, R.; Climent. F.; Grisolia, S. Vanadate increases oxygen affinity and affects enzyme activities and membrane properties of erythrocytes. Biochem. Biophys. Res. Commun., 1981, 103, 111-117.
110. Climent, F.; Bartrons. R.; Pons, G.; Carreras, J. Effect of vanadate on phosphoryl transfer enzymes involved in glucose metabolism. Biochem. Biophys. Res. Commun., 1981, 101, 570-576.
111. Carreras, J.; Climent, F.; Bartrons, R.; Pons, G. Effect of vanadate on the formation and stability of the phosphoenzyme forms of 2, 3-bisphosphoglycerate-dependent phosphoglycerate mutase and of phosphoglucomutase. Biochim. Biophys. Acta, 1982, 705, 238-242.
112. Esteller, M.; Ureña. J.; Carreras, J.; Martelly, I.; Climent, F. Thyroid hormone stimulates phosphoglycerate mutase activity and isozyme transition in rat muscle tissues. Life Sci., 1994, 59, 533-538.
113. Gonzalez-Cinca, N.; Gonzalo, S.; Ascaso, C.; Carreras, J.; Climent F. Effects of thyroid hormone on mRNA of phosphoglycerate mutase subunits in rat muscle during development. Horm. Res., 2002, 57, 48-52.
114. Gonzalez-Cinca N.; Pérez de la Ossa, P.; Carreras, J.; Climent, F. Effects of thyroid hormone and hypoxia on 2, 3-bisphosphoglycerate, bisphosphoglycerate synthase and phosphoglycerate mutase in rabbit erythroblasts and reticulocytes in vivo. Horm. Res., 2004, 62, 191-196.
115. Gonzalez-Cinca N.; Ribera, F.; Carreras, J.; Climent, F. Effects of hypoxia and thyroid hormone on mRNA levels and activity of phosphoglycerate mutase in rabbit tissues. Horm. Res., 2003, 59, 16-20.
116. Brent, G.A.; Moore, D. D.; Larsen, P.R. Thyroid hormonere gulation of gene expression. Annu. Rev. Physiol., 1991, 53, 17-35.
117. Katz, D.; Lazar, M.H. Dominant negative activity of an endogenous thyroid receptor variant (alpha 2) is due to competition for binding sites on target tissues. J. Biol. Chem., 1993, 268, 20904-20910.
118. Brent, G.A. Mechanism of disease: The molecular basis of thyroid hormone action. N. Engl. J. Med., 1994, 331, 847-853.
119. Jameson, J.L. In Endocrinology.; DeGroot, L.U.; Jameson, L.J.; Eds.; Saunders: Philadelphia, 2001.; Vol. 2, pp.1327-1344.
120. Ureña, J.M.; Egea, G.; Graña, X.; Castellá. J.; Marsal, J.; Carreras, J.; Climent, F. Location of phosphoglycerate mutase in rat muscle. An immunocytochemical and biochemistry study. Eur. J. Cell Biol., 1990, 51, 151-156.
121. Egea, G.; Ureña, J.M.; Graña, X.; Marsal, J.; Carreras, J.; Climent, F. Nuclear location of phosphoglycerate mutase BB isozyme in rat tissues. Histochemistry, 1992, 97, 269-275.
122. Sibert, G. Enzyme und substrate der glykolyse in isolierten zellkernen. Biochem. Zeitschr. 1961, 334, 369-387.
123. Di Mauro, S.; Miranda, A.F.; Khan, S.; Gitlin, K.; Friedman, R. Human muscle phosphoglycerate mutase deficiency: newly discovered metabolic myopathy. Science, 1981, 212, 1277-1279.
124. Di Mauro, S.; Miranda, A, F.; Olarte, M.; Fieman, R.; Hays, A. Muscle phosphoglycerate mutase deficiency. Neurology, 1982, 32, 584-591.
125. Shin, J. OH.; Kyung-Seok, P.; Hewitt, F.R.; Morris, J.D.; Jiesheng, L.U.; Ali, B.N.; Di Mauro, S. Exercise-induced cramp, myoglobinuria and tubular aggregates in phosphoglycerate mutase deficiency. Muscle Nerve, 2006, 34, 572-576.
126. Poulton, K. R.; Khan, A. A.; Rossi, M. L.; Riddoch, D. Muscle phosphoglycerate mutase deficiency: a study of a family with metabolic myopathy. Func. Neurol., 1994, 9, 47-58.
127. Repiso, A.; Pérez de la Ossa, P.; Avilés, X.; Oliva, B.; Juncá, J.; Oliva, R.; Garceia, E.; Vives-Corrons, J.L.; Carreras, J.; Climent, F. Red blood cell phosphoglycerate mutase. Description of the first human BB isozyme mutation. Haematologica, 2003, 88(03), ECR07.
128. Tsujino, S.; Shanske, S.; Sakoda, S.; Fenichel, G.; Di Mauro, S. The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency. Am. J. Hum. Genet. 1993, 52, 472-477.
129. Tsujino, S.; Shanske, S.; Sakoda, S.; Toscano, A.; Di Mauro, S. Molecular genetic studies in muscle phosphoglycerate mutase (PGAM) deficiency. Muscle Nerve, 1995, Suppl 3, S50-S53.
130. 31P-MR spectroscopy. J. Neurol., 1994, 241, 289-294.
131. Toscano, A.; Tsujino, S.; Vita, G.; Shanske. S.; Messina, C.; Di Mauro, S. Molecular basis of muscle phosphoglycerate mutase (PGAM) deficiency in the Italian kindred. Muscle Nerve, 1996, 19, 1134-1137.
132. Kawashima, N.; Mishima. M.; Shindo, R.; Hirano, M.; Kuwabara, S.; Saitoh, H.; Miyazaki, T. Partial deficiency of phosphoglycerate mutase with diabetic polyneuropathy: the first Japanese patient. Internal. Med., 1996, 35, 799-802.
133. Hadjigeourgiou, G.; Kawashima, N.; Bruno.C.; Andreu, A.L.; Sue, C.M.; Ridgen, D.J.; Kawashima, A.; Shanske, S.; Di Mauro, S. Manifesting heterozygotes in a Japanese family with a novel mutation in the muscle-specific phosphoglycerate mutase (PGAM-M) gene. Neuromuscul. Dis., 1999, 9, 399-402.
134. Repiso, A.; Ramirez Bajo, M.J.; Vives Corrons, J.L.; Carreras, J.; Climent, F. Phosphoglycerate mutase BB isozyme deficiency in a patient with non-spherocytic anemia: familial and metabolic studies. Haematologica, 2005, 90, 257-259.
135. Andrés, V.; Carreras, J.; Cussó, R. Regulation of muscle phosphofructokinase by physiological concentrations of bisphosphorylated hexoses: effect of alkalinization. Biochem. Biophys. Res. Commun., 1990, 172, 328-338.
136. Atauri, P.; Repiso, A.; Oliva, B.; Vives-Corrons, J.L.; Climent, F.; Carreras, J. Characterization of the first described mutation of human red blood cell phosphoglycerate mutase. Biochem. Biophys. Acta, 2005, 1740, 403-410.
137. Fothergill-Gilmore, L.A.; Michels, P.A. Evolution in glycolysis. Prog. Biophys. Mol. Biol., 1983, 59, 105-227.
138. Tani, K.; Yoshida, M.C.; Satoh, H.; Mitamura, K.; Noguchi, T.; Tanaka, T.; Fujii, H.; Miwa, S. Human M2-type pyruvate kinase: cDNA cloning, chromosomal assignment and expression in hepatoma. Gene, 1988, 20, 509-516.
139. Noguchi, T.; Inoue, H.; Tanaka, T. The M1 and M2 type isozymes of pyruvate kinase are produced from a same gene by alternative RNA splicing. J. Biol. Chem., 1986, 261, 13807-13812.
140. Zanella, A.; Fermo, E.; Bianchi, P.; Valentini. Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br. J. Haematol., 2005, 130, 11-25.
141. Satoh, H.; Tani, K.; Yoshida, M.C.; Sasaki, M.; Miwa, S.; Fujii, H. The human liver-type pyruvate kinase (PKL) gene is on chromosome 1 at band q21. Cytogenet. Cell Genet., 1988, 47, 132-133.
142. Kanno, H.; Fujii, H.; Hirono, A.; Miwa, S. cDNA cloning of human R-type pyruvate kinase and identification of a single amino-acid substitution (Thr384→Met) affecting enzymatic stability in a pyruvate kinase variant (PK Tokyo) associated with hereditary hemolytic anemia. Proc. Nat. Acad Sci. USA, 1991, 88, 8218-8221.
143. Wang, C.; Chiarelli, L.R.; Bianchi, P.; Abraham, D.J.; Galizzi, A.; Mattewi, A.; Zanella, A.; Valentine, G. Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing hemolytic anemia. Blood, 2001, 98, 3113-3120.
144. Zanella, A.; Fermo, E.; Bianchi, P.; Chiarelli, L.R.; Valentini, G. Pyruvate kinase deficiency: The genotype-phenotype association. Blood Rev., 2007, 21, 217-231.
145. Valentini G.; Chiarelli, L.R.; Fortin, R.; Dolzan, M.; Gallizzi, A.; Abraham, D.J.; Wanh, C.; Bianchi, P.; Zanella, A.; Mattevi, A. Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia. J. Biol. Chem., 2002, 277, 23807-23814.
146. Valentine, W.N.; Tanaka, K.R.; Miwa, S. A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non-specific hemolytic anemia. Trans. Assoc. Am. Phys., 1961, 74, 100-110.
147. Zanella, A.; Bianchi, P. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations. Baillière's Clin. Haematol., 2000, 13, 57-81.